Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Clear all

1,609 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20038
200410
200513
200611
200718
200825
200934
201024
201134
201240
201351
201450
201583
201676
201787
201893
2019145
2020125
2021149
2022127
2023160
2024112
202567
202655

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed834
Unknown status300
Recruiting179
Terminated95
Active, not recruiting81
Not yet recruiting55
Withdrawn44
Enrolling by invitation18
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University23
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)20
Gilead Sciences16
Massachusetts General Hospital16
Cairo University15
Pfizer15
AstraZeneca14
University of California, San Diego14
Columbia University13
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis12

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease1,609
Fatty Liver265
Obesity230
Diabetes Mellitus, Type 2136
Liver Cirrhosis135
Liver Diseases93
Metabolic Syndrome93
Fibrosis92
Insulin Resistance90
Diabetes Mellitus73

Trials

Showing 26 to 50 of 1,609. Each trial links to its page on Pharma Observatory.

1,509 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.